Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FPHAX vs. ETHSX: which is better?

Bottom line

FPHAX vs ETHSX: the short answer

FPHAX (Pharmaceuticals Portfolio) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are quite different portfolios: only about 38% of their top holdings (by weight) are shared.

FPHAX is cheaper at 0.67% vs 1.18% — a difference of $51 a year per $10,000 invested.

Over five years, FPHAX returned +12.6% a year vs +5.3% for ETHSX (reporting dates differ).

ETHSX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

FPHAX vs ETHSX side by side

FPHAXETHSX
TypeMutual fundMutual fund
Fund familyFidelityMorgan Stanley
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.67%1.18%
Annual cost per $10k$67$118
10-yr cost on $10k (prospectus)$835$1,911
Max front load—5.25%
12b-1 fee0%0.25%
1-yr return+30.3%−1.9%
5-yr return (annualized)+12.6%+5.3%
10-yr return (annualized)+10.0%+6.4%
Best quarter+18.5%+14.2%
Worst quarter−13.6%−12.1%
Net assets (fund)$1.5B$757.9M
Number of holdings5742
Portfolio turnover77%3%
Returns as ofApr 30, 2026Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFPHAXETHSXDifference
2024+9.4%+3.5%+5.9%
2023+12.5%+5.7%+6.9%
2022+1.0%−9.4%+10.4%
2021+11.8%+22.1%−10.2%
2020+11.1%+13.0%−2.0%
2019+31.6%+26.0%+5.6%
2018+5.8%+6.0%−0.2%
2017+10.7%+16.2%−5.5%
2016−16.3%−14.9%−1.4%

Source: Fund prospectus bar charts

Holdings overlap

7 of FPHAX's top 25 holdings also appear in ETHSX's top 25.

Shared top holdings
HoldingFPHAXETHSX
ELI LILLY and CO28.78%12.47%
MERCK and CO INC4.74%5.08%
Roche Holding Ag4.54%5.44%
Astrazeneca Plc4.22%6.24%
Gilead Sciences Inc3.97%3.34%
JOHNSON and JOHNSON3.77%6.45%
Royalty Pharma Plc2.67%1.58%

Source: SEC Form N-PORT

FPHAX top 10

  1. ELI LILLY and CO — 28.78%
  2. Gsk Plc — 8.17%
  3. Viatris Inc — 5.45%
  4. Ucb Sa — 5.09%
  5. MERCK and CO INC — 4.74%
  6. Roche Holding Ag — 4.54%
  7. Legend Biotech Corp — 4.53%
  8. Astrazeneca Plc — 4.22%
  9. Elanco Animal Health Inc — 4.15%
  10. Jazz Pharmaceuticals Plc — 4.09%

ETHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

FAQ

What is the difference between FPHAX and ETHSX?
FPHAX (Pharmaceuticals Portfolio) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are quite different portfolios: only about 38% of their top holdings (by weight) are shared. FPHAX is cheaper at 0.67% vs 1.18% — a difference of $51 a year per $10,000 invested.
Which is cheaper, FPHAX or ETHSX?
FPHAX has the lower expense ratio (0.67%).
Should I own both FPHAX and ETHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.